Biogen Idec Research Limited

Neurodegenerative disease and motor neuron disorders

Research activity includes spinal muscular atrophy, amyotrophic lateral sclerosis linked to SOD1 mutation, Parkinson’s disease, and mild cognitive impairment due to Alzheimer’s disease.

  • Spinal muscular atrophy
  • Amyotrophic lateral sclerosis with SOD1 mutation
  • Parkinson’s disease
  • Alzheimer’s disease–related cognitive decline

The portfolio also extends to long-term neurological follow-up and treatment persistence in inherited and progressive nervous system disorders.

Multiple sclerosis and central nervous system inflammation

Clinical research covers relapsing forms of multiple sclerosis, including relapsing-remitting multiple sclerosis and pediatric RRMS, with attention to inflammatory activity within the central nervous system.

  • Relapsing-remitting multiple sclerosis
  • Relapsing forms of multiple sclerosis
  • Pediatric multiple sclerosis
  • Brain inflammation and MRI-defined disease activity

Work in this area also includes continued evaluation of disease control and longer-term neurological outcomes.

Lupus and cutaneous autoimmune disease

The sponsor funds studies in systemic lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous lupus erythematosus, including cases with systemic features and refractory skin disease.

  • Systemic lupus erythematosus
  • Subacute cutaneous lupus erythematosus
  • Chronic cutaneous lupus erythematosus
  • Autoimmune skin and systemic manifestations

These studies focus on both skin activity and broader autoimmune involvement in adult populations.

Kidney transplantation and immune-mediated renal disease

Research includes kidney transplant recipients with late antibody-mediated rejection and microvascular inflammation, alongside primary renal autoimmunity such as IgA nephropathy.

  • Late antibody-mediated rejection
  • Late isolated microvascular inflammation
  • IgA nephropathy
  • Transplant-related immune injury

The renal portfolio reflects interest in both post-transplant complications and chronic immune-driven kidney disease.

Inherited retinal disease and rare genetic disorders

Additional studies address choroideremia, X-linked retinitis pigmentosa, and Friedreich’s ataxia, highlighting involvement in inherited conditions affecting vision and neurology.

  • Choroideremia
  • X-linked retinitis pigmentosa
  • Friedreich’s ataxia
  • Rare genetic disease

These programs include disorders with progressive sensory, retinal, and neurologic impairment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Long-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany
  • Study on the Safety and Effectiveness of Peginterferon Beta-1a for Children and Teens with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Bulgaria Croatia Czechia Hungary Slovakia
  • Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

    Not recruiting

    4 1
    Investigated Drugs:
    Belgium Bulgaria France Germany Hungary Italy +5
  • Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Austria France Germany Italy The Netherlands Poland +1
  • Evaluating Higher Dose Nusinersen in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam

    Not recruiting

    3 1 1
    Investigated Drugs:
    Germany Hungary Italy
  • Study of Nusinersen for Patients with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Germany Italy Spain